Skip to main content

Journals in Medical research

  • The Journal of Molecular Diagnostics

    • ISSN: 1525-1578
    Official journal of the Association for Molecular Pathology (AMP)The Journal of Molecular Diagnostics (JMD), the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods which may be applied to diagnosis or monitoring of disease or disease predisposition.
  • Advances in Integrative Medicine

    • ISSN: 2212-9588
    Advances in Integrative Medicine (AIMED) is an international peer-reviewed, evidence-based research and review journal that is multi-disciplinary within the fields of Integrative and Complementary Medicine.The journal focuses on rigorous quantitative and qualitative research including systematic reviews, clinical trials and surveys, whilst also welcoming medical hypotheses and clinically-relevant articles and case studies disclosing practical learning tools for the consulting practitioner.By promoting research and practice excellence in the field, and cross collaboration between relevant practitioner groups and associations, the journal aims to advance the practice of IM, identify areas for future research, and improve patient health outcomes.Internation... networking is encouraged through clinical innovation, the establishment of best practice and by providing opportunities for cooperation between organisations and communities.
  • Clinical Therapeutics

    • ISSN: 0149-2918
    Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drugs, biologicals, and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research and development. In addition, Clinical Therapeutics features updates on specific topics collated by expert Topic Editors and Guest Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot study reports that assess drug safety and tolerability in all phases of development, new routes of drug administration and formulations, pharmacokinetics, pharmacodynamics, bioavailability, and biosimilarity and changes in practice guidelines, standards, policies and regulations are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of publicly accessible evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials.Beyond therapeutic clinical applications, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.In addition to feature articles published monthly, Clinical Therapeutics regularly features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not selected for the updates will be considered for general publication. Submit your manuscript at https://www.editoria... manuscript types require prior editorial review before submission to ensure alignment with the journal’s scope and contribution to the field. Authors intending to submit the following types of studies should seek pre-submission approval by contacting the journal office at [email protected]... with a brief description of the proposed manuscript for editorial evaluation:Adverse event studies based on the FAERS database. Submissions must clearly articulate the novel contribution of the study and how it advances the existing literature. This justification should also be included in the cover letter.Drug–drug interaction studies. Manuscripts must provide a clear methodological rationale for the selection of the agents studied, including clinical or mechanistic justification described within the Methods section.Studies focused on alternative or complementary medicines, including traditional medical systems (e.g., Traditional Chinese Medicine) or supplementation-focu... interventions.Out-of... ContentClinical Therapeutics focuses on clinically relevant therapeutic research and studies with clear implications for patient care, therapeutic development, or health policy. The following manuscript categories are generally considered outside the scope of the journal and are not suitable for submission:Animal or preclinical studies without direct clinical applicationSimple innovator versus generic bioequivalence studies without broader clinical, pharmacological, or regulatory implicationsMendelia... randomization studiesMolecular docking or purely computational modeling studies without experimental or clinical validationHighly specialized discipline-specific studies (e.g., dermatology-, ophthalmology-, or imaging-focused research) that lack clear therapeutic relevance or broader clinical applicability